EANS-Tip Announcement: SYGNIS Pharma AG / Correction of an announcement according to Articles 37v, 37w, 37x et seqq. of the WpHG (the German Securities Act) with the objective of Europe-wide distribution

--------------------------------------------------------------------------------
Tip announcement for financial statements transmitted by euro adhoc. The
issuer is responsible for the content of this announcement.
--------------------------------------------------------------------------------

This is an announcement of change.

The company SYGNIS Pharma AG is declaring its financial reporting publication
plan below:

Report Type: Group-Yearly Report
German:
Publication Date : 30.04.2013
Publication Location: http://www.sygnis.de/investoren/finanzberichte
English:
Publication Date : 30.04.2013
Publication Location:
http://www.sygnis.de/investor_relations/financial_reports/index_eng.html

end of announcement euro adhoc
--------------------------------------------------------------------------------

issuer:      SYGNIS Pharma AG
             Im Neuenheimer Feld 515
             D-69120 Heidelberg
phone:       +49 (0)6221 454-6
FAX:         +49 (0)6221 454-777
mail:        [email protected]
WWW:         http://www.sygnis.de
sector:      Biotechnology
ISIN:        DE000A1RFM03
indexes:     CDAX, Prime All Share

stockmarkets: free trade: Hannover, Berlin, München, Hamburg, Düsseldorf,
Stuttgart, regulated dealing/prime standard: Frankfurt
language: English

ORIGINAL APA-OTS TEXT - THE INFORMATION CONTAINED IN THIS PRESS RELEASE IS SUBJECT TO THE EXCLUSIVE RESPONSIBILITY OF THE ISSUER | EAE

print